Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
Emerging approaches to diagnosing metabolic disease focus on a comprehensive panel of biomarkers, enabling early detection of risks including inflammation, nutrient deficiencies, and insulin resistance before progression to chronic illnesses. Metabolic disease is increasingly being understood as more than a…
A new analysis suggests that the GLP-1 receptor agonist Mounjaro could significantly lower heart attack and overall cardiovascular risk in people with type 2 diabetes and established heart disease, prompting calls for further research. A large American analysis published in…
Cheryl’s year-long journey illustrates how gradual lifestyle modifications, including diet and weight loss, can effectively reverse prediabetes and eliminate the need for medication, challenging the reliance on drugs alone. Cheryl’s journey began with a warning that many patients hear and…
After nearly three years of denial following his Type 2 diabetes diagnosis, Mark Savary turned personal struggle into a powerful campaign advocating for better access, reduced stigma, and improved treatment options for South Africans living with diabetes. Mark Savary spent…
Recent studies suggest that incorporating almonds into a diabetes-friendly diet may help improve blood sugar control, highlighting their potential as a beneficial snack for people with type 2 diabetes. For people living with diabetes, snacks that are filling without causing…
Doctors in Kashmir report a surge in chronic illnesses such as obesity, diabetes, and fatty liver, signalling a lifestyle crisis that threatens to overwhelm the region’s health system and underscores the urgent need for early intervention and lifestyle изменений. Doctors…
A large review indicates that gum disease, particularly periodontitis, could be an early warning sign for type 2 diabetes, highlighting the importance of oral health in disease prevention. A visit to the dentist may reveal more than cavities or worn…
Eli Lilly has filed its oral GLP-1 medication orforglipron with the US FDA, aiming to revolutionise diabetes treatment with a tablet that offers manufacturing ease and potential for increased patient access amidst ongoing supply and regulatory challenges. Eli Lilly has…
New research indicates that metformin, traditionally used for type 2 diabetes, could offer protective benefits against rejection and graft failure among kidney transplant recipients on tacrolimus, prompting calls for further investigation into its immunomodulatory effects. Metformin, a long-established first-line treatment…
SAB Biotherapeutics progresses its lead type 1 diabetes treatment into further testing phases, expands manufacturing capacity, and receives strategic grants amid rising R&D investment and a significant stock index inclusion. SAB Biotherapeutics said its lead type 1 diabetes programme moved…
Research indicates that tirzepatide, the active ingredient in Mounjaro, not only helps control blood sugar and weight but also significantly reduces the risk of heart attacks and serious cardiovascular events in patients with type 2 diabetes and heart disease, signalling…
Women with polycystic ovary syndrome are increasingly using GLP-1 receptor agonists like Ozempic and Mounjaro to manage weight and insulin resistance as part of fertility preparation, raising questions about safety, timing, and long-term outcomes. GLP-1 drugs such as Ozempic, Wegovy…
